| Net sales | 33.54a | 32.36a | 31.23a |
| Costs and expenses | — | — | — |
| Cost of products sold, excluding amortization of intangible assets | -11.63a | -11.22a | -10.72a |
| Research and development expense | -2.73a | -2.74a | -2.7a |
| Selling, general, and administrative expense | -10.85a | -10.74a | -10.42a |
| Amortization of intangible assets | -1.81a | -1.69a | -1.7a |
| Restructuring charges, net | -0.27a | -0.23a | -0.38a |
| Certain litigation charges, net | -0.32a | -0.15a | -0.03a |
| Other operating (income) expense, net | -0.02a | 0.46a | -0.13a |
| Operating profit | 5.96a | 5.14a | 5.49a |
| Other non-operating income, net | -0.4a | -0.41a | -0.52a |
| Interest expense, net | -0.73a | -0.72a | -0.64a |
| Income before income taxes | 5.63a | 4.84a | 5.36a |
| Income tax provision | -0.94a | -1.13a | -1.58a |
| Net income | 4.69a | 3.71a | 3.78a |
| Net income attributable to noncontrolling interests | -0.03a | -0.03a | -0.03a |
| Net income attributable to Medtronic | 4.66a | 3.68a | 3.76a |